Petit mal epilepsy and Suicidal behavior
Summary:
Suicidal behavior is found among people with Petit mal epilepsy, especially for people who are female, 40-49 old.
The study analyzes which people have Suicidal behavior with Petit mal epilepsy. It is created by eHealthMe based on reports of 31 people who have Petit mal epilepsy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Petit mal epilepsy?
Petit mal epilepsy (absence seizure) is found to be associated with 345 drugs and 612 conditions by eHealthMe. Check the latest studies of Petit mal epilepsy.
What is Suicidal behavior?
Suicidal behavior is found to be associated with 288 drugs and 449 conditions by eHealthMe. Check the latest studies of Suicidal behavior.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
31 people who have Petit Mal Epilepsy and Suicidal Behavior are studied.

Gender of people who have Petit Mal Epilepsy and experienced Suicidal Behavior *:
- female: 100 %
- male: 0.0 %
Age of people who have Petit Mal Epilepsy and experienced Suicidal Behavior *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 14 people, 45.16%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 9 people, 29.03%
Common drugs taken by these people *:
- Clobazam: 18 people, 58.06%
- Zonisamide: 1 person, 3.23%
- Valproic Acid: 1 person, 3.23%
- Topiramate: 1 person, 3.23%
- Topamax: 1 person, 3.23%
- Progesterone: 1 person, 3.23%
- Levetiracetam: 1 person, 3.23%
- Lamotrigine: 1 person, 3.23%
- Dilantin: 1 person, 3.23%
Common symptoms for these people *:
- Depressed Mood: 30 people, 96.77%
- Multiple-Drug Resistance: 22 people, 70.97%
- Drug Ineffective: 16 people, 51.61%
- Indigestion: 10 people, 32.26%
- Drowsiness: 9 people, 29.03%
- Dizziness: 9 people, 29.03%
- Nausea And Vomiting: 7 people, 22.58%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 3.23%
- Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 3.23%
- Memory Loss: 1 person, 3.23%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Suicidal behavior?
- Check whether Suicidal behavior is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Petit mal epilepsy (7,767 reports)
- Suicidal behavior (4,940 reports)
All the drugs that are associated with Suicidal behavior:
- Suicidal behavior (288 drugs)
All the conditions that are associated with Suicidal behavior:
- Suicidal behavior (449 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Suicidal behavior and Petit mal epilepsy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cancer - Throat Or Larynx and Dermatitis Acneiform - 3 seconds ago
- Could Letrozole cause Stroke? - 4 seconds ago
- Rosuvastatin Calcium vs. Bystolic, side effect and effectiveness comparison - 4 seconds ago
- Could Ventolin Hfa cause Vital Capacity Decreased? - 4 seconds ago
- Garcinia Cambogi vs. Ephedra, side effect and effectiveness comparison - 9 seconds ago
- Could Piperacillin And Tazobactam cause Oral Herpes? - 11 seconds ago
- Could Trichlormethiazide cause Dyslipidaemia? - 13 seconds ago
- Could Lopressor cause Atherosclerosis? - 14 seconds ago
- Drug interactions of Omeprazole and Atorvastatin Calcium - 15 seconds ago
- Could Digoxin cause Premature Delivery? - 17 seconds ago